Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
ACADSB encodes short/branched-chain acyl-CoA dehydrogenase (SBCAD), and biallelic variants cause autosomal recessive 2-methylbutyryl-CoA dehydrogenase deficiency ([MONDO:0012392]). This inborn error of L-isoleucine metabolism presents with variable neurologic features, including athetoid cerebral palsy (HP:0011445) and autism spectrum disorders (HP:0000717).
Inheritance is autosomal recessive. Across two newborn-screening cohorts, 4 affected individuals from 2 Hmong families and 12 non-Hmong probands have been reported with biallelic ACADSB variants, including splice-site and missense alleles ([PMID:12837870], [PMID:20547083]).
Segregation analyses in multiple families demonstrated co-segregation of the IVS3+3A>G (c.303+3A>G) splice mutation with metabolite abnormalities in affected siblings and an asymptomatic carrier mother ([PMID:17883863]).
Functional assays confirm pathogenicity: patient fibroblast enzyme activity is abolished using 2-methylbutyryl-CoA substrate ([PMID:11013134]), minigene splicing assays show exon skipping due to c.303+3A>G ([PMID:16317551]), and bacterial expression of novel missense alleles yields unstable or inactive enzymes.
The clinical spectrum ranges from severe motor delay and cerebral palsy to asymptomatic infancy under dietary management, indicating variable expressivity and incomplete penetrance.
Integration of genetic, segregation, and functional data supports a strong gene–disease relationship. Early detection by tandem mass spectrometry newborn screening enables presymptomatic dietary intervention.
Gene–Disease AssociationStrongApproximately 16 probands across 12 families with biallelic ACADSB variants and concordant biochemical phenotypes Genetic EvidenceStrong17 affected individuals with confirmed biallelic variants in ACADSB across Hmong and non-Hmong cohorts; AR segregation in multiplex families Functional EvidenceModerateEnzyme assays in patient fibroblasts, bacterial expression studies, and splicing assays consistently demonstrate loss of SBCAD function ([PMID:11013134], [PMID:16317551]) |